Literature DB >> 25565719

Total cystectomy and subsequent urinary diversion to the prepuce or vagina in dogs with transitional cell carcinoma of the trigone area: a report of 10 cases (2005-2011).

Kohei Saeki1, Atsushi Fujita1, Naoki Fujita1, Takayuki Nakagawa1, Ryohei Nishimura1.   

Abstract

The cases of 10 dogs with transitional cell carcinoma of the urinary bladder that underwent total cystectomy were retrospectively reviewed to evaluate the feasibility and outcome of total cystectomy and ureteral transplantation to the prepuce or vagina. Dehiscence of ureterostomy (n = 2), pyelonephritis (n = 3), oliguria (n = 2), azotemia (n = 1), and ureteral obstruction (n = 1) were observed complications. The estimated median survival time was 385 days. This study demonstrates the feasibility of total cystectomy and subsequent urinary diversion to the prepuce or vagina in dogs. Compared to previous ureterocolonic anastomosis, this technique is associated with fewer gastrointestinal and neurologic complications.

Entities:  

Mesh:

Year:  2015        PMID: 25565719      PMCID: PMC4266061     

Source DB:  PubMed          Journal:  Can Vet J        ISSN: 0008-5286            Impact factor:   1.008


  21 in total

1.  Toxic effects and antitumor response of gemcitabine in combination with piroxicam treatment in dogs with transitional cell carcinoma of the urinary bladder.

Authors:  Laura Marconato; Eric Zini; Donna Lindner; Lisa Suslak-Brown; Victoria Nelson; Ann K Jeglum
Journal:  J Am Vet Med Assoc       Date:  2011-04-15       Impact factor: 1.936

2.  Complications after radical cystectomy: analysis of population-based data.

Authors:  Badrinath R Konety; Veerasathpurush Allareddy; Harry Herr
Journal:  Urology       Date:  2006-06-27       Impact factor: 2.649

3.  Antitumor effects of deracoxib treatment in 26 dogs with transitional cell carcinoma of the urinary bladder.

Authors:  Sarah K McMillan; Pedro Boria; George E Moore; William R Widmer; Patty L Bonney; Deborah W Knapp
Journal:  J Am Vet Med Assoc       Date:  2011-10-15       Impact factor: 1.936

4.  Naturally-occurring canine transitional cell carcinoma of the urinary bladder A relevant model of human invasive bladder cancer.

Authors:  D W Knapp; N W Glickman; D B Denicola; P L Bonney; T L Lin; L T Glickman
Journal:  Urol Oncol       Date:  2000 Mar-Apr       Impact factor: 3.498

5.  Clinical trial of vinblastine in dogs with transitional cell carcinoma of the urinary bladder.

Authors:  E J Arnold; M O Childress; L M Fourez; K M Tan; J C Stewart; P L Bonney; D W Knapp
Journal:  J Vet Intern Med       Date:  2011-09-13       Impact factor: 3.333

6.  Ureterocolonic anastomosis in a dog with transitional cell carcinoma of the urinary bladder.

Authors:  R D Montgomery; G H Hankes
Journal:  J Am Vet Med Assoc       Date:  1987-06-01       Impact factor: 1.936

7.  Clinical evaluation of mitoxantrone and piroxicam in a canine model of human invasive urinary bladder carcinoma.

Authors:  Carolyn J Henry; Dudley L McCaw; Susan E Turnquist; Jeff W Tyler; Lina Bravo; Sarah Sheafor; Rodney C Straw; William S Dernell; Bruce R Madewell; Linda Jorgensen; Michael A Scott; Mary Lynn Higginbotham; Ruthanne Chun
Journal:  Clin Cancer Res       Date:  2003-02       Impact factor: 12.531

Review 8.  Surgical and chemotherapeutic management of regional lymph nodes in bladder cancer.

Authors:  Todd M Morgan; Samuel D Kaffenberger; Michael S Cookson
Journal:  J Urol       Date:  2012-08-15       Impact factor: 7.450

9.  Ureterocolonic anastomosis in ten dogs with transitional cell carcinoma.

Authors:  E A Stone; S J Withrow; R L Page; P D Schwarz; S L Wheeler; H B Seim
Journal:  Vet Surg       Date:  1988 May-Jun       Impact factor: 1.495

10.  Piroxicam therapy in 34 dogs with transitional cell carcinoma of the urinary bladder.

Authors:  D W Knapp; R C Richardson; T C Chan; G D Bottoms; W R Widmer; D B DeNicola; R Teclaw; P L Bonney; T Kuczek
Journal:  J Vet Intern Med       Date:  1994 Jul-Aug       Impact factor: 3.333

View more
  6 in total

1.  Clinical outcomes of dogs with transitional cell carcinoma receiving medical therapy, with and without partial cystectomy.

Authors:  Marcus L Bradbury; Christine M Mullin; Shaban D Gillian; Chick Weisse; Philip J Bergman; Michelle A Morges; Lauren R May; David M Vail; Craig A Clifford
Journal:  Can Vet J       Date:  2021-02       Impact factor: 1.008

2.  Treatment of genitourinary carcinoma in dogs using nonsteroidal anti-inflammatory drugs, mitoxantrone, and radiation therapy: A retrospective study.

Authors:  Benoit Clerc-Renaud; Tracy L Gieger; Susan M LaRue; Michael W Nolan
Journal:  J Vet Intern Med       Date:  2021-02-26       Impact factor: 3.333

3.  Lapatinib as first-line treatment for muscle-invasive urothelial carcinoma in dogs.

Authors:  Shingo Maeda; Kosei Sakai; Kenjiro Kaji; Aki Iio; Maho Nakazawa; Tomoki Motegi; Tomohiro Yonezawa; Yasuyuki Momoi
Journal:  Sci Rep       Date:  2022-01-13       Impact factor: 4.379

4.  Comparison of outcomes between medical and surgical treatment in dogs with prostatic adenocarcinoma: a retrospective study.

Authors:  Keigo Iizuka; Kumiko Ishigaki; Mamiko Seki; Takahiro Nagumo; Kei Tamura; Naoki Sakurai; Kazuyuki Terai; Kazushi Asano
Journal:  BMC Vet Res       Date:  2022-01-15       Impact factor: 2.741

Review 5.  Molecular Markers in Urinary Bladder Cancer: Applications for Diagnosis, Prognosis and Therapy.

Authors:  Ana Mafalda Rasteiro; Eva Sá E Lemos; Paula A Oliveira; Rui M Gil da Costa
Journal:  Vet Sci       Date:  2022-02-28

6.  Laparoscopic-assisted cutaneous ureterostomy in a canine patient with prostatic carcinoma.

Authors:  Giovanni Allevi; Carlotta Spediacci; Elena Marchesi; Marco Trovatelli
Journal:  Vet Med Sci       Date:  2021-07-08
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.